A Study of Chemotherapy Plus ddI or ddC in the Treatment of AIDS-Related Kaposi's Sarcoma

NCT00000954 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

72

Enrollment

NIH

Sponsor class

Conditions

Sarcoma, Kaposi
HIV Infections

Interventions

DRUG: Bleomycin sulfate
DRUG: Vincristine sulfate
DRUG: Doxorubicin hydrochloride
DRUG: Zalcitabine
DRUG: Didanosine

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]
[object Object]